Post-arrival TB Screening of the High-Risk Refugees and Immigrants in Maryland Natasha Chida, MD MSPH Baltimore City Health Department March 22 nd, 2016.

Slides:



Advertisements
Similar presentations
A typical day in the TB clinic You see the following patients in the TB clinic. All have normal CXRs: 1. A 35 year old man from Hartford with a 16 mm positive.
Advertisements

Health Assessment Abnormal Cases. Objective Review Health Assessment Status transitions for abnormal cases Record HA (Health Assessment) Results for an.
Module 2 - Epidemiology of Tuberculosis
PAEDIATRIC TB Jenny Handforth June Overview Why is Paediatric TB important Epidemiology- know the patients Adult v child with TB - differences?
Continuity Clinic Tuberculosis. Continuity Clinic Objectives Know current epidemiologic trends in TB Know indications for testing for TB exposure and.
TB Contact Investigation
TB in North Dakota: Changing Demographics John R. Baird, MD, MPH Fargo Cass Public Health North Dakota Department of Health April 11, 2012.
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
World Health Organization TB Case Definitions
B WAIVERS: A YEAR IN REVIEW MARCH 20, 2014 MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE PREVENTION AND HEALTH PROMOTION ADMINISTRATION ANDREA E. PALMER,
CDC Update on the 2007 TB Technical Instructions Sharmila Shetty, MD Immigrant, Refugee & Migrant Health Branch Division of Global Migration and Quarantine.
OSHA Blood Borne Pathogen and Tuberculosis Training PART II Tuberculosis Author: Maxine Edwards, RN, ICP ECU Infection Control Presented by: Patti Goetz,
Living with HIV, Dying of TB Intensified TB case finding among people living with HIV Adapted from presentation by Colleen Daniels TB/HIV Advocacy Stop.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
In the name of God Fariba Rezaeetalab Assistant Professor.
Tuberculosis in Children and Young Adults
Diagnosis of TB.
“You want me to take how many months of medication?”:
Latent Tuberculosis among Displaced Populations Rapid Diagnosis and Control Nikolaou Aristidis MD, MSc.
Unit 5: IPT Isoniazid TB Preventive Therapy
Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in.
 Pulmonary Tuberculosis BY: MOHAMED HUSSEIN. Cause  Caused by Mycobacterium tuberculosis (M. tuberculosis)  Gram (+) rod (bacilli). Acid-fast  Pulmonary.
TB Elimination in California Can We Get There? Navigating the Landmines CTCA April 28, 2011 Jennifer Flood MD MPH Chief, Tuberculosis Control Branch California.
New Entrant TB Screening Dr. John P. Watson Consultant Respiratory Physician.
Assessment of Tuberculosis Risk in Family Care Clinic Christopher Gordon, M.D. Kris Lee, M.D. RCRMC – Moreno Valley, CA.
The Changing Landscape of TB: Maryland TB in 2013 Presented by Dr. David Blythe Lisa Paulos, RN MPH, Epidemiologist Center for TB Control & Prevention.
IGRAs in Practice: The San Francisco Health Department Experience Jennifer Grinsdale, MPH Program Manager/Epidemiologist Acting Director Tuberculosis Control.
HAIVN Harvard Medical School AIDS Initiative in Vietnam
Use of 12 weekly doses of isoniazid and rifapentine for the treatment of latent tuberculosis − Connecticut , Kelley Bemis, MPH CDC/CSTE Applied.
Denise F. Johnson, MPH, MBA LaShaunda L. Malone, MSPH Catherine M. Stein, PhD American Public Health Association Meeting November 5, 2013 Boston, MA. The.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Tuberculosis in Virginia? Wendy Heirendt, MPA Public Health Advisor Division of TB Control Virginia Department of Health September 12, 2005.
Sanghyuk Shin, PhD Department of Epidemiology UCLA Fielding School of Public Health Aug 27, 2015 Tuberculosis and HIV Co-infection: “A Deadly Syndemic”
Module 2 - Epidemiology of Tuberculosis
Tuberculosis The evolution of a bacterium. 2 World Health Organization (WH.O. declared TB a global health emergency in cases per 100,
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
The Epidemiology of Tuberculosis Lex Gibson, Virginia TB Program.
Tuberculosis August 17, 2010 Tuberculosis Mycobacterium tuberculosis – Fastidious, aerobic, acid-fast bacillus Tremendous increase in incidence over.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
Extrapulmonary tuberculosis and HIV Outi Vehviläinen, MD Ilembula Lutheran Hospital
More information © 2015 Denver Public Health Michelle K Haas, Kaylynn Aiona, Pete Dupree, Ellen Brilliant, Robert Belknap Improving access to Tuberculosis.
TB Transmission What is TB? aTB is a disease caused by infection with a bacteria called Mycobacterium tuberculosis.
Sunil Kumar, B.K.Kapoor, Urvinderpal Singh, Vidhu Mittal Department of Pulmonary Medicine, GMC,Patiala PRESENTATION OF PULMONARY TUBERCULOSIS IN ELDERLY.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Tuberculosis in Children and Young Adults
“You want me to take how many months of medication?”: Advising your patient on risks vs. benefits of LTBI treatment David Horne, MD, MPH Division of Pulmonary.
The Epidemiology of Tuberculosis Lex Gibson, Director Virginia TB Program.
Diagnosis of pulmonary tuberculosis
TB Control Program County of San Diego County of San Diego Health and Human Services Agency Tuberculosis Control Branch Trends in Tuberculosis Highlights.
TB PREVENTION by Assoc. Prof. Dr. Nik Sherina Haidi Hanafi 1.
Case Discussion 2 - TB IN CHILDREN by Dr. Jeyaseelan P. Nachiappan & Dr. Suryati Adnan 1 Picture of CPG Cover.
Prevalence of Pulmonary Tuberculosis among the Somali Population in Minnesota Sahur Hussein, Sponsers; Dr. Blinnikov, Mikhail; Antunez, Hector Giovanni.
Assessment of Tuberculosis Risk in Family Care Clinic
Management of the Newborn When Maternal TB Suspected
Zachary White, MPH Drew L. Posey, MD, MPH
Whole-Genome Sequencing; It’s Not Just For Epis
14/02/1396.
This is an archived document.
William Burman Denver Public Health Tuberculosis Trials Consortium
TUBERCULOSIS IN VIRGINIA
اهمیت سل در چیست؟ حدود یک سوم جمعیت جهان(2 میلیارد نفر)با میکروب سل آلوده شده اند سالانه 9 میلیون نفر به سل فعال مبتلا می شوند هر ساله 1/5 تا 2 میلیون.
Tuberculosis in prisons TUBS02
Tb: Screening & Diagnosis (1)
Meeting the Challenges of Multi-Site Studies in Diverse Populations
Presentation transcript:

Post-arrival TB Screening of the High-Risk Refugees and Immigrants in Maryland Natasha Chida, MD MSPH Baltimore City Health Department March 22 nd, 2016

Objectives Review TB disease and infection among foreign-born persons in the United States and Maryland Review TB disease among B-waivers at the Baltimore City Health Department Review data on symptoms and CXR findigns among immigrants with active TB Discuss Maryland TB screening protocol for B waivers

Objectives Review TB disease and infection among foreign-born persons in the United States and Maryland Review TB disease among B-waivers at the Baltimore City Health Department Review data on symptoms and CXR findings among immigrants with active TB Discuss Maryland TB screening protocol for B waivers

B-Waivers All Class B immigrants are to report to local health department 84% of TB cases in foreign-born residents of the United States are attributable to progression of LTBI acquired in the patient’s home country Evans TB, et al. Int J Tuberc Lung Dis. 2015;19(2):231-6 CDC. Reported Tuberculosis in the United States

TB in the United States 9,421 cases in 2014 Foreign-born: 66% Maryland: 81% Primary MDR TB between Foreign-born: 25%  85% : 15 XDR cases; 11 foreign-born CDC. Reported Tuberculosis in the United States Reporting area TotalTB symptoms Abnormal CXR Immigrant Med Exam Other United States (57.6)1934 (20.5)203 (2.2)1861 (19.7) Maryland (63.6)43 (21.7)4 (2)25 (12.7) Primary Reason for TB Evaluation, 2014

CDC. Reported Tuberculosis in the United States TB in the United States TB Cases and Percentages in Foreign-born Person by Immigration Status at First Entry, 2014 Reporting areaTotalImmigrant VisaRefugeeAsylee or ParoleeOther United States6215 (66)1486 (23.9)402 (6.5)30 (0.5)4297 (69) Maryland160 (81)67 (41.9)10 (6.3)3 (1.9)80 (50) TB Cases and Percentages in Foreign-born Person by Number of Years in the US, 2014 Reporting area Total< 1 year ≥20Unknown United States6215 (66)995 (16)919 (14.8)848 (13.6)1168 (18.8)1705 (27.4)580 (9.3) Maryland160 (81)40 (25)33 (20.6)24 (15)36 (22.5)25 (15.6)2 (1.3)

Maryland B-Waivers, Keen et al. Program evaluation of tuberculosis B-waiver arrival epidemiologic data in Maryland, DHMH

Maryland B-Waivers, ,488 B-waivers: Immigrants: 70% Refugees: 28% Asylees: 2% LTBI: 675 (52%  66% treated) Immigrants: 43% LTBI (59% treated) Refugees: 52% LTBI (81% treated) Asylees: 31% LTBI (44% treated) Keen et al. Program evaluation of tuberculosis B-waiver arrival epidemiologic data in Maryland, DHMH. NTCA.

Refugees more likely to be LTBI (p<0.001) Active TB: 19 (<1%) 75% male Median time from arrival to evaluation: 40 days Maryland B-Waivers, Keen et al. Program evaluation of tuberculosis B-waiver arrival epidemiologic data in Maryland, DHMH. NTCA.

Objectives Review TB disease and infection among foreign-born persons in the United States and Maryland Review TB disease among B-waivers at the Baltimore City Health Department Review data on symptoms and CXR findings among immigrants with active TB Discuss Maryland TB screening protocol for B waivers

Nuzzo JB, et al. Am J Public Health. 2015;105(7): Baltimore City retrospective review of B-waivers

Country of origin Nepal: 64% Philippines: 12% Ethiopia: 6% Median time to evaluation: 75 days (IQR days) Median time from pre-immigration CXR to evaluation 201 days (IQR days) Nuzzo JB, et al. Am J Public Health. 2015;105(7):

Baltimore City retrospective review of B-waivers B1: 71% B2 28% CharacteristicB1 (n=108) No. (%) B2 (n=43) No. (%) B3 (n=2) No (%) All classes P Any symptoms at time of evaluation19 (18)1 (2)0 (0)20 (13).034 Abnormal post-immigration CXR62 (57)3 (7)0 (0)65 (43)<.001 Completed med eval99 (2)43 (100)2 (100)144 (94)- Active TB5 (99)1 (2)0 (0)6 (144)- LTBI39 (39)35 (43)2 (100)76 (53)- No current LTBI/TB55 (56)7 (43)0 (0)62 (43)<.001

Active cases among BCHD B-waivers Nuzzo JB, et al. Am J Public Health. 2015;105(7):

Active cases among BCHD B-waivers Nuzzo JB, et al. Am J Public Health. 2015;105(7):

6 active cases 1 pulmonary and extrapulmonary (spine) 2 pediatric 3 Nepal/Bhutan, 2 Ethiopia/Eritrea, 1 Iraqi 1 treated 30 years prior 5 in US 1 year; year 1 contact with LTBI All HIV negative Active cases among BCHD B-waivers Nuzzo JB, et al. Am J Public Health. 2015;105(7):

Active cases among BCHD B-waivers No DM, HIV, homeless, smoking, IVDU/EtOH 5 abnormal post-immigration CXR: 1infiltrate 1 infiltrate and LUL fibrosis 1 nodule (symptomatic) 1 hilar masslike opacity (symptomatic) 1 medistinal/hilar LAD Nuzzo JB, et al. Am J Public Health. 2015;105(7):

Active cases among BCHD B-waivers 4 cases asymptomatic Evaluated based on radiographic features/clinical exam 2/4 culture positive All received 6 months of HRZE 1 previously treated X 18 months 1 B2 Nuzzo JB, et al. Am J Public Health. 2015;105(7):

Active cases among BCHD B-waivers 2 cases symptomatic 1 with cough and hemoptysis 1 with cough, weight loss, poor appetite 1 with + contact 1 with TB spine + pulm TB Nuzzo JB, et al. Am J Public Health. 2015;105(7):

Objectives Review TB disease and infection among foreign-born persons in the United States and Maryland Review TB disease among B-waivers at the Baltimore City Health Department Review data on symptoms and CXR findings among immigrants with active TB Discuss Maryland TB screening protocol for B waivers

Active Disease in Immigrants BCHD : 4% active 2010 analysis of CDC EDN Children 2-14 with LTBI diagnosis upon arrival; 3% active San Diego analysis of adults refugees with LTBI; 1.5% active 124,114 Filipino immigrants to California, followed 9 years; 0.6% active 72% in first year of immigration Taylor EM, et al. J Immigr Minor Health [Epub ahead of print] PMID Bennett RJ, et al. Am J Public Health. 2014;104(4):e95-e102 Walter ND, et al. Am J Respir Crit Care Med ; 189(1): 88–95.

Asymptomatic TB in foreign-born cases 1830 inmates entering a federal detention center in San Diego during 6 months in cases 60% foreign born 81% asymptomatic 94% with abnormal CXR Saunders DL, et al. Public Health Rep May-Jun; 116(3): 210–218.

Asymptomatic TB in foreign-born cases at 20 US sites Davidow AL, et al. Am J Public Health. 2015;105(9):e81-8. CharacteristicNo (% of total) or Median (IQR) Persons with TB diagnosed within 6 months of arrival (n=151) Symptoms before diagnosis With symptoms83 (52.3) No symptoms68 (47.7) Persons with TB diagnosed ≥ 6 months after arrival (829) Time since arrival months47 (6) 1-2 y68 (8) 3-5 y183 (22) >5531 (64) Symptoms before diagnosis <50 d before214 (25.2) d before234 (26.2) >175 d before213 (24.4) No symptoms168 (24.1) 980 TB patients who reported their visa status, stratified by time from US arrival to diagnosis,

Chest X Rays and TB diagnosis Evaluation of foreign-borne persons diagnosed with TB in the US between ,970 total cases 28% diagnosed within 2 years of entry Caine KP, et al. JAMA. 2008;300(4): Abnormal CXRNormal or no CXR Time since entry, months No of cases Pulm cases Pos smearNeg smear, pos culture Pos smearNeg smear, pos culture Neg smear, neg culture < (91)1211 (30)1502 (37)31 (1)101 (2)1259 (31) < (88)1924 (32)2066 (34)40 (1)133 (2)1873 (32) Reported TB Cases among Foreign-Born Persons in the United States Less than 3 and 6 months,

Pre-immigration screening, symptoms, CXR 83,214 persons screened in China between cases 81% asymptomatic 92% with abnormal CXR 14,098 persons screened between in Vietnam 183 cases 82% symptomatic All had abnormal CXR Liang S, et al. BMC Public Health (2015) 15:231 Maloney SA, et al. Arch Intern Med Jan 23;166(2):

Objectives Review TB disease and infection among foreign-born persons in the United States and Maryland Review TB disease among B-waivers at the Baltimore City Health Department Review data on symptoms and CXR findigns among immigrants with active TB Discuss Maryland TB screening protocol for B waivers

Maryland B-waivers, Fibrosis= “fibrosis,” “apical” or “upper lobe” scarring, and “pleural fibrosis” CharacteristicN=518% Fibrosis on CXR5811 B15391 Immigrants4985 Refugees712 Asylees12 Sputum collected4985 Sputum positive for MTB24

Optimal screening for B-waivers? Are symptoms a good screening tool? Are CXRs a good screening tool? Mean time to pre-immigration CXR and evaluation 201 days Is it practical to obtain CXR and have patient come back? Den Boon, et al. Int J Tuberc Lung Dis Aug;10(8): van't Hoog AH, et al. PLoS One. 2012;7(7):e Baltimore CityMarylandVirginiaMinnesotaCurry Center B1Obtain sputa if symptoms OR abnormal CXR Obtain sputa if symptomatic Obtain sputaObtain sputa if symptomatic Obtain sputa B2Obtain sputa if symptoms OR abnormal CXR Obtain sputa if symptomatic